Prednisolone Trial in Children Younger Than 4 Years

Key facts

Sponsor

All India Institute of Medical Sciences

Principal Investigator

Arvind Bagga, MD

All India Institute of Medical Sciences, New Delhi, India

Intervention

Prednisolone(drug)

Enrollment

170 target

Eligibility

1-4 years · All sexes

Timeline

2015 – 2021

Study locations (5)

• Cedars-Sinai Medical Center, Pediatric IBD & Pediatric Nephrology, Los Angeles, California, United States
• Stanford University Medical Center, Department of Pediatrics, Division of Nephrology, Stanford, California, United States
• University of Michigan Department of Pedatric Nephrology, Ann Arbor, Michigan, United States
• Levine's Children/Carolinas HealthCare System, Charlotte, North Carolina, United States
• All India Institute of Medical Sciences, New Delhi, National Capital Territory of Delhi, India

Collaborators

NephCure Accelerating Cures Institute · University of Michigan · Department of Biotechnology, Government of India (funding agency)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Idiopathic nephrotic syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT06820866
  Non-invasive Diagnosis of Idiopathic Nephrotic Syndromes
  Assistance Publique - Hôpitaux de Paris
• ACTIVE NOT RECRUITINGPHASE3NCT05627557
  A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome
  Hoffmann-La Roche
• RECRUITINGNCT04207580
  A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.
  University Hospital, Limoges

See all trials for Idiopathic nephrotic syndrome →